Chris Lewis
Stock Analyst at Roth Capital
(3.03)
# 1,272
Out of 5,127 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $7.67 | -47.85% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $105.15 | -84.78% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $34.51 | -57.98% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.35 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.43 | +1,298.60% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $7.67
Upside: -47.85%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $105.15
Upside: -84.78%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $34.51
Upside: -57.98%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $103.35
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.43
Upside: +1,298.60%